Themis Beteiligungs-Aktiengesellschaft

Themis Beteiligungs-Aktiengesellschaft is a declared insider of Dermapharm Holding SE, with filings sourced from BaFin. We count 3 filings; the first trade dates from 30 October 2025 and the latest from 14 May 2026.

Purchases make up the whole of the open-market record (3 purchases, €107.9M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €36.3M and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 15 May 2026, the filings show an open-market purchase worth €17.8M in Dermapharm Holding SE. The median gap between a trade and its publication by BaFin is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by BaFin and describes the past, not future prices; it is not investment advice.